LILIAN DJAMILA SILVA: Open Payments
NPI 1063100451 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 35 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $676 · 2025 $1,146
Food & beverage: $1,146
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $200 |
| Neurocrine BioSciences, Inc. | 2 | $189 |
| Vanda Pharmaceuticals Inc. | 9 | $169 |
| Janssen Pharmaceuticals, Inc | 2 | $161 |
| Axsome Therapeutics, Inc. | 2 | $68 |
| Indivior Inc. | 2 | $51 |
Products named: REXULTI, CAPLYTA, INGREZZA, FANAPT, SPRAVATO, Auvelity, ABILIFY ASIMTUFII, SUBLOCADE.
Industry payments across MA — which companies pay providers there.
